AJ
Abrar Jalal Ahmed
About Abrar Jalal Ahmed
Data last updated:
Abrar Jalal Ahmed is a Director at Rexwin Pharma Private Limited (since 2017). The company operates in Business Services. Rexwin Pharma Private Limited reported revenue of ₹8.5 Lakh (FY 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rexwin Pharma Private Limited U74999MH2017PTC294930 | Director | 16 May 2017 | 2017 | ₹8.5 Lakh (FY 2019) | Active |
Board colleagues of Abrar Jalal Ahmed
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abhaypratap Bhupendra Singh | 07797978 | Rexwin Pharma Private Limited | Director |
| Mohit Sharma | 07797976 | Rexwin Pharma Private Limited | Director |
| Rikin Ram Gaikar | 07798477 | Rexwin Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Abrar Jalal Ahmed
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abrar Jalal Ahmed
Abrar Jalal Ahmed currently holds 1 directorship: Rexwin Pharma Private Limited (Director, since 16 May 2017, revenue ₹8.5 Lakh (FY 2019)).
Abrar Jalal Ahmed was first appointed on 16 May 2017 as Director at Rexwin Pharma Private Limited.
The current boards of Abrar Jalal Ahmed's companies include Abhaypratap Bhupendra Singh (Rexwin Pharma Private Limited), Mohit Sharma (Rexwin Pharma Private Limited), Rikin Ram Gaikar (Rexwin Pharma Private Limited).